The dual role of the TSC complex in cancer

Josephine Hartung1, Christine Müller1, Cornelis F Calkhoven1

  • 1European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9700 AD Groningen, The Netherlands.

PubMed

Insights

The tuberous sclerosis complex (TSC) proteins regulate cell growth by inhibiting mTORC1. While often tumor suppressive, TSC proteins can promote certain cancers, necessitating new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) proteins (TSC1/TSC2/TBC1D7) are key inhibitors of mechanistic target of rapamycin complex 1 (mTORC1), a critical regulator of cell growth.
  • Mutations in TSC1 or TSC2 lead to TSC, a genetic disorder causing benign tumors in multiple organs.
  • Traditionally viewed as tumor suppressors, TSC proteins exhibit dual roles in cancer, sometimes promoting tumorigenesis.

Purpose of the Study:

  • To review the composition and function of the TSC protein complex.
  • To elucidate the roles of individual TSC components in cancer biology.
  • To explore potential therapeutic targeting strategies for TSC-related cancers.

Main Methods:

  • Literature review of existing studies on TSC protein complex.
  • Analysis of the roles of TSC1, TSC2, and TBC1D7 in various cancer types.
  • Identification of potential therapeutic targets based on TSC protein functions.

Main Results:

  • The TSC complex's primary function is mTORC1 inhibition, impacting cell growth and proliferation.
  • Evidence suggests TSC proteins can act as oncogenes in specific cancer contexts, contradicting their tumor-suppressive roles.
  • Understanding the dual role of TSC proteins is crucial for developing effective cancer therapies.

Conclusions:

  • The TSC complex plays a complex role in cancer, acting as both a tumor suppressor and promoter.
  • Further research into the context-dependent functions of TSC proteins is essential.
  • Targeting the TSC pathway offers potential for novel cancer treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K